Drug-induced bronchopulmonary pleural disease

Area of Science:

• Pulmonology
• Clinical Pharmacology

Background:

• Over 75 drugs are known to cause adverse effects on the bronchopulmonary system.
• Many drug-induced lung injuries are fatal if not recognized and managed promptly.
• The lack of a mandatory reporting system in the US means less than 5% of adverse lung drug reactions are likely reported.

Purpose of the Study:

• To raise clinician awareness of drugs causing pulmonary adverse effects.
• To provide a classification of drugs with known pulmonary toxicity.
• To emphasize the importance of considering drug history in diagnosing pulmonary symptoms.

Main Methods:

• Review and classification of drugs known to produce adverse pulmonary effects.
• Categorization includes chemotherapeutic, cardiovascular, antibiotic, anti-inflammatory agents, and others.
• Discussion of diagnostic challenges and clinical presentation.

Main Results:

• Drugs can cause serious, potentially fatal, pulmonary adverse effects.
• No specific diagnostic tests exist for drug-induced lung disease; diagnosis relies on clinical suspicion.
• Pulmonary function tests and chest imaging findings are often nonspecific but correlate with symptoms.

Conclusions:

• Clinicians must be vigilant for drug-induced pulmonary toxicity.
• Prompt recognition and cessation of offending agents are critical for patient outcomes.
• A thorough medication history is essential for diagnosing unexplained pulmonary symptoms.